TRIP13 anticorps (C-Term)
Aperçu rapide pour TRIP13 anticorps (C-Term) (ABIN955331)
Antigène
Voir toutes TRIP13 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 370-400, C-Term
-
Specificité
- This antibody detects TRIP13 (C-term).
-
Réactivité croisée (Details)
- Species reactivity (tested):Human
-
Purification
- Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
-
Immunogène
- KLH conjugated synthetic peptide between 370-400 amino acids from the C-terminal region of human TRIP13
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2 - 8 °C for up to six months or (in aliquots) at -20 °C for longer.
-
-
- TRIP13 (Thyroid Hormone Receptor Interactor 13 (TRIP13))
-
Autre désignation
- TRIP13
-
Sujet
- This gene encodes a protein that interacts with thyroid hormone receptors, also known as hormone-dependent transcription factors. The gene product interacts specifically with the ligand binding domain. This gene is one of several that may play a role in early-stage non-small cell lung cancer.Synonyms: 16E1-BP, HPV16 E1 protein-binding protein, Human papillomavirus type 16 E1 protein-binding protein, TRIP-13, Thyroid hormone receptor interactor 13, Thyroid receptor-interacting protein 13
-
ID gène
- 9319
-
NCBI Accession
- NP_004228
Antigène
-